Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New treatments in adult cystic fibrosis.

× No keyword cloud information.

18 in total

1. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.

Authors: N G McElvaney; R C Hubbard; P Birrer; M S Chernick; D B Caplan; M M Frank; R G Crystal
Journal: Lancet Date: 1991-02-16 Impact factor: 79.321

2. Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment.

Authors: B Frederiksen; S Lanng; C Koch; N Høiby
Journal: Pediatr Pulmonol Date: 1996-03

3. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.

Authors: M R Knowles; N L Church; W E Waltner; J R Yankaskas; P Gilligan; M King; L J Edwards; R W Helms; R C Boucher
Journal: N Engl J Med Date: 1990-04-26 Impact factor: 91.245

4. Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch.

Authors: M F Tosi; H Zakem; M Berger
Journal: J Clin Invest Date: 1990-07 Impact factor: 14.808

5. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto.

Authors: M Corey; F J McLaughlin; M Williams; H Levison
Journal: J Clin Epidemiol Date: 1988 Impact factor: 6.437

6. Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.

Authors: R B Fick; G P Naegel; S U Squier; R E Wood; J B Gee; H Y Reynolds
Journal: J Clin Invest Date: 1984-07 Impact factor: 14.808

7. Cystic fibrosis: current survival and population estimates to the year 2000.

Authors: J S Elborn; D J Shale; J R Britton
Journal: Thorax Date: 1991-12 Impact factor: 9.139

8. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.

Authors: M W Konstan; K A Hilliard; T M Norvell; M Berger
Journal: Am J Respir Crit Care Med Date: 1994-08 Impact factor: 21.405

9. The changing epidemiology of cystic fibrosis.

Authors: S C FitzSimmons
Journal: J Pediatr Date: 1993-01 Impact factor: 4.406

10. No added benefit from nebulized amiloride in patients with cystic fibrosis.

Authors: A Graham; A Hasani; E W Alton; G P Martin; C Marriott; M E Hodson; S W Clarke; D M Geddes
Journal: Eur Respir J Date: 1993-10 Impact factor: 16.671